Christoph Brackmann, Chief Financial Officer at NovoCure Ltd (NVCR), sold 6,412 shares at $13.31 ($85K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Open-market sale of $85k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.